Brief fixation does not hamper the reliability of Ki67 analysis in breast cancer core-needle biopsies: A double-centre study

Shona Kalkman, Joris P. Bulte, Altuna Halilovic, Peter Bult, Paul J. van Diest

Research output: Contribution to journalArticle

Abstract

Aims: Immunohistochemical assessment of Ki67 expression in core-needle biopsies (CNBs) is increasingly playing a role in therapeutic decision-making for breast cancer patients. Within the framework of same-day diagnosis of breast lesions, fixation times are markedly decreased. We therefore attempted to validate Ki67 analysis in briefly fixed breast cancer CNBs. Methods and results: CNBs of 136 consecutive patients with invasive breast cancer diagnosed through the same-day diagnosis programme of both the University Medical Centre Utrecht (UMCU) and the Radboud University Medical Centre (RUMC) were included. CNBs were fixed in formaldehyde for approximately 45 min at the UMCU and for between 60 and 90 min at the RUMC. Immunohistochemistry for Ki67 expression was compared between the briefly fixed CNBs and conventionally fixed resection specimens of the same tumour. The overall agreement between CNBs and resections was 122 of 142 (85.9%) (κ = 0.71; 95% CI 0.60-0.83). Positive and negative predictive values were 79.7% (95% CI 67-88%) and 91.0% (95% CI 82-96%), respectively. Conclusions: Overall agreement for Ki67 expression was good between briefly fixed CNBs and conventionally fixed resection specimens, and within the range of studies comparing conventionally fixed CNBs and resections.

Original languageEnglish (US)
Pages (from-to)380-387
Number of pages8
JournalHistopathology
Volume66
Issue number3
DOIs
StatePublished - Feb 1 2015
Externally publishedYes

Fingerprint

Large-Core Needle Biopsy
Breast Neoplasms
Formaldehyde
Decision Making
Breast
Immunohistochemistry

Keywords

  • Breast cancer
  • Cell proliferation
  • Core-needle biopsy
  • Fixation time
  • Immunohistochemistry
  • Ki67

ASJC Scopus subject areas

  • Histology
  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Brief fixation does not hamper the reliability of Ki67 analysis in breast cancer core-needle biopsies : A double-centre study. / Kalkman, Shona; Bulte, Joris P.; Halilovic, Altuna; Bult, Peter; van Diest, Paul J.

In: Histopathology, Vol. 66, No. 3, 01.02.2015, p. 380-387.

Research output: Contribution to journalArticle

Kalkman, Shona ; Bulte, Joris P. ; Halilovic, Altuna ; Bult, Peter ; van Diest, Paul J. / Brief fixation does not hamper the reliability of Ki67 analysis in breast cancer core-needle biopsies : A double-centre study. In: Histopathology. 2015 ; Vol. 66, No. 3. pp. 380-387.
@article{482b26cb805a445188698aaa89945397,
title = "Brief fixation does not hamper the reliability of Ki67 analysis in breast cancer core-needle biopsies: A double-centre study",
abstract = "Aims: Immunohistochemical assessment of Ki67 expression in core-needle biopsies (CNBs) is increasingly playing a role in therapeutic decision-making for breast cancer patients. Within the framework of same-day diagnosis of breast lesions, fixation times are markedly decreased. We therefore attempted to validate Ki67 analysis in briefly fixed breast cancer CNBs. Methods and results: CNBs of 136 consecutive patients with invasive breast cancer diagnosed through the same-day diagnosis programme of both the University Medical Centre Utrecht (UMCU) and the Radboud University Medical Centre (RUMC) were included. CNBs were fixed in formaldehyde for approximately 45 min at the UMCU and for between 60 and 90 min at the RUMC. Immunohistochemistry for Ki67 expression was compared between the briefly fixed CNBs and conventionally fixed resection specimens of the same tumour. The overall agreement between CNBs and resections was 122 of 142 (85.9{\%}) (κ = 0.71; 95{\%} CI 0.60-0.83). Positive and negative predictive values were 79.7{\%} (95{\%} CI 67-88{\%}) and 91.0{\%} (95{\%} CI 82-96{\%}), respectively. Conclusions: Overall agreement for Ki67 expression was good between briefly fixed CNBs and conventionally fixed resection specimens, and within the range of studies comparing conventionally fixed CNBs and resections.",
keywords = "Breast cancer, Cell proliferation, Core-needle biopsy, Fixation time, Immunohistochemistry, Ki67",
author = "Shona Kalkman and Bulte, {Joris P.} and Altuna Halilovic and Peter Bult and {van Diest}, {Paul J.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1111/his.12521",
language = "English (US)",
volume = "66",
pages = "380--387",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Brief fixation does not hamper the reliability of Ki67 analysis in breast cancer core-needle biopsies

T2 - A double-centre study

AU - Kalkman, Shona

AU - Bulte, Joris P.

AU - Halilovic, Altuna

AU - Bult, Peter

AU - van Diest, Paul J.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Aims: Immunohistochemical assessment of Ki67 expression in core-needle biopsies (CNBs) is increasingly playing a role in therapeutic decision-making for breast cancer patients. Within the framework of same-day diagnosis of breast lesions, fixation times are markedly decreased. We therefore attempted to validate Ki67 analysis in briefly fixed breast cancer CNBs. Methods and results: CNBs of 136 consecutive patients with invasive breast cancer diagnosed through the same-day diagnosis programme of both the University Medical Centre Utrecht (UMCU) and the Radboud University Medical Centre (RUMC) were included. CNBs were fixed in formaldehyde for approximately 45 min at the UMCU and for between 60 and 90 min at the RUMC. Immunohistochemistry for Ki67 expression was compared between the briefly fixed CNBs and conventionally fixed resection specimens of the same tumour. The overall agreement between CNBs and resections was 122 of 142 (85.9%) (κ = 0.71; 95% CI 0.60-0.83). Positive and negative predictive values were 79.7% (95% CI 67-88%) and 91.0% (95% CI 82-96%), respectively. Conclusions: Overall agreement for Ki67 expression was good between briefly fixed CNBs and conventionally fixed resection specimens, and within the range of studies comparing conventionally fixed CNBs and resections.

AB - Aims: Immunohistochemical assessment of Ki67 expression in core-needle biopsies (CNBs) is increasingly playing a role in therapeutic decision-making for breast cancer patients. Within the framework of same-day diagnosis of breast lesions, fixation times are markedly decreased. We therefore attempted to validate Ki67 analysis in briefly fixed breast cancer CNBs. Methods and results: CNBs of 136 consecutive patients with invasive breast cancer diagnosed through the same-day diagnosis programme of both the University Medical Centre Utrecht (UMCU) and the Radboud University Medical Centre (RUMC) were included. CNBs were fixed in formaldehyde for approximately 45 min at the UMCU and for between 60 and 90 min at the RUMC. Immunohistochemistry for Ki67 expression was compared between the briefly fixed CNBs and conventionally fixed resection specimens of the same tumour. The overall agreement between CNBs and resections was 122 of 142 (85.9%) (κ = 0.71; 95% CI 0.60-0.83). Positive and negative predictive values were 79.7% (95% CI 67-88%) and 91.0% (95% CI 82-96%), respectively. Conclusions: Overall agreement for Ki67 expression was good between briefly fixed CNBs and conventionally fixed resection specimens, and within the range of studies comparing conventionally fixed CNBs and resections.

KW - Breast cancer

KW - Cell proliferation

KW - Core-needle biopsy

KW - Fixation time

KW - Immunohistochemistry

KW - Ki67

UR - http://www.scopus.com/inward/record.url?scp=84921611197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921611197&partnerID=8YFLogxK

U2 - 10.1111/his.12521

DO - 10.1111/his.12521

M3 - Article

C2 - 25234295

AN - SCOPUS:84921611197

VL - 66

SP - 380

EP - 387

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 3

ER -